Skip to main content
Clinical Trials/NCT04023058
NCT04023058SuspendedNot Applicable

Stress Echo for Ischemic Mitral Valve Surgery

Saint Petersburg State University, Russia1 site in 1 country400 target enrollmentStarted: January 1, 2020Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Suspended
Sponsor
Enrollment
400
Locations
1
Primary Endpoint
cardiac death

Study Overview

Brief Summary

Comparison patients with CABG alone vs. CABG+mitral surgery with non-massive ischaemic mitral regurgitation (IMR) depending on stress echo data.

Detailed Description

Chronic ischaemic mitral regurgitation (IMR) is a frequent complication of coronary artery disease (CAD), and is associated with a poor prognosis and outcome. The role of concomitant mitral valve surgery for IMR in patients undergoing coronary artery bypass grafting (CABG) remains controversial. After myocardial infarction IMR is associated with poor outcome and prognosis with double mortality rates, it reduces survival following surgical or percutaneous revascularization. However, there is no consensus on the cut-off value of IMR. The thresholds to define severe secondary mitral regurgitation are need to be evaluated with regards to their impact on prognosis after mitral valve intervention. The European guidelines is defined effective regurgitant orifice (ERO)-0.2 cm2 and regurgitant volume (RV)-30ml, as the threshold for severe IMR, because of severe prognosis of this group. Whereas American guidelines are defined it as ERO-0.4 cm2 and RV-60ml, as it was no evidence to impact intervention on the IMR with ERO-0.2 cm2 and RV-30ml. Partly it's explained by the dynamic nature of the secondary MR. About 30% of patients from the group with non-massive regurgitation at rest, have dramatically increasing it during exercise. However, some patient have not changes or decreasing IMR during exercise and, probably, they have not such a negative impact on the hemodynamic by IMR. The pervious comparative studies, that were the base for recommendations did not differ the patients with and without changes IMR during exercise. The current guidelines doesn't support the stress echo (SE) exams before operation for assessing necessity in mitral valve operation. It's due to lack of information that prove of influence for survival after surgery depending on IMR dynamic parameters.

IMR study hypothesis: Stress echocardiography data, including ERO, RV, pulmonary pressure (PA) pressure, beta-lines - B-lines, contractile reserve, could be indications for mitral valve intervention in patient with CAD and chronic secondary mitral regurgitation, undergoing CABG. The patients of the group with non-massive (ERO-0.2 cm2 and RV-30ml) IMR have positive effect by mitral surgery if they have increasing IMR during exercise test. The group with massive IMR (ERO≥0.4 cm2 and RV≥60 ml) will be better according clinic, echo, stress echo results in comparison with non-massive non-operated subgroup.

Aim: To assess the value of stress echo testing for ischemic mitral surgery indication in patients undergoing CABG.

Inclusion criteria for all projects are:

  1. Age > 18 years
  2. IMR, ERO≥0.2 cm2 and RV≥30 ml.
  3. Indication for CABG

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Ischemic MR, ERO≥0.2 cm2 and RV≥30 ml.
  • •Indication for CABG

Exclusion Criteria

  • •Unwillingness to give informed consent and to enter a regular follow-up program.
  • •Contraindications for SE.

Arms & Interventions

CABG/increasing MR

No Intervention

non-massive IMR with increasing IMR during exercise - CABG only

CABG+mitral surgery (MS)/increasing MR

Experimental

non-massive IMR with increasing IMR during exercise - CABG+ mitral surgery

Intervention: Mitral surgery (Procedure)

CABG/non-increasing MR

No Intervention

non-massive IMR non-increasing IMR during exercise - CABG only

CABG+MS/non-increasing MR

Experimental

non-massive IMR non-increasing IMR - CABG+ mitral surgery

Intervention: Mitral surgery (Procedure)

Control 1

Other

massive IMR at rest without increasing during exercise - CABG+ mitral surgery

Intervention: Mitral surgery (Procedure)

Control 2

Other

massive IMR at rest with increasing during exercise - CABG+ mitral surgery

Intervention: Mitral surgery (Procedure)

Outcomes

Primary Outcomes

cardiac death

Time Frame: during 3 year

cardiac death

new hospital readmission

Time Frame: during 3 year from including

new hospitalization

myocardial infarction

Time Frame: during 3 year

myocardial infarction

all-cause death

Time Frame: during 3 year

all-cause death

re-operation

Time Frame: during 3 year

percutaneous coronary intervention, coronary bypass surgery, heart transplant

Secondary Outcomes

  • B-lines(Change from Baseline at 12 months, at 3 years)
  • Contractile reserve(Change from Baseline at 12 months, at 3 years)
  • effective regurgitant orifice(Change from Baseline at 12 months, at 3 years)
  • physical capacity(Change from Baseline of physical capacity in Watts at 12 months, at 3 years)
  • left atrium volume(Change from Baseline of left atrium volume at 12 months, at 3 years)
  • end diastolic volume of left ventricle(Change from Baseline of end diastolic volume of left ventricle at 12 months, at 3 years)
  • ejection fraction at rest and during stress echo(Change from Baseline of ejection fraction at 12 months, at 3 years)
  • right ventricle size(Change from Baseline at 12 months, at 3 years)
  • pulmonary artery pressure pressure(Change from Baseline at 12 months, at 3 years)

Investigators

Sponsor
Saint Petersburg State University, Russia
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Efremov Sergey

Deputy director for science

Saint Petersburg State University, Russia

Study Sites (1)

Loading locations...

Similar Trials